Submitted by Anonymous (not verified) on 20 February 2025 - 13:43
Orphan designation: Elraglusib Treatment of pancreatic cancer, 16/01/2025 Positive
Source:
Orphan designation: Elraglusib Treatment of pancreatic cancer, 16/01/2025 Positive